ArticleACS omega2026
Photophysical Investigation of Coumarin Solubilization in Polyethylene Glycol Mediated by a 1,2,4-Triazolium Protic Ionic Liquid.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymers are remarkable macromolecules that can be fabricated with ease for the required potential applications, including biotechnology, medicine, engineering, and nanotechnology. Biocompatible and biodegradable polymers are now widely adopted in pharmaceutical formulations, since they offer better solubilization and enhanced bioavailability. One of the biggest challenges to pharmaceutical research is the poor aqueous solubility of hydrophobic drug molecules, which results in limited bioavailability and reduced therapeutic performance. In this work, well-established biocompatible polymer polyethylene glycol (PEG) is employed as the pharmaceutical excipient for the hydrophobic drug coumarin (COU). Along with PEG, a synthesized room-temperature triazolium-based protic ionic liquid (PIL) was incorporated as an additive, and their synergetic effect on COU solubilization was studied by exploring the photophysical properties of COU using steady-state and time-resolved fluorescence techniques. The experiments reveal that incorporation of COU into the PEG/IL system significantly alters the emission intensity, spectral position, and excited-state lifetime, indicating strong nanoenvironmental modulation. Quenching studies indicate the controlled accessibility of COU, suggesting that it is partially confined within PEG rather than entirely encapsulated. A 1,2,4-triazolium-based PIL/polymer platform enhances COU solubilization, where the polymer provides a confined environment for improved solubility and stability and the PIL enables fine control over local polarity, structural organization, and molecular accessibility. Overall, these results demonstrate that PEG/IL systems provide a versatile and reliable platform for enhancing the solubility, stability, and photophysical properties of hydrophobic drug molecules, which underscores their promise for advanced pharmaceutical formulations and sensing applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.